Justin Y. Garber

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Causal effects of multiple sclerosis therapies in left-truncated registry data.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 21, 2026

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis.

Journal: Brain : a journal of neurology
Published: March 12, 2026

Transient global amnesia as a paraneoplastic manifestation of small cell lung cancer.

Transient global amnesia as a paraneoplastic manifestation of small cell lung cancer.

Journal: Journal of neuroimmunology
Published: March 01, 2026

Neurological implications of chimeric antigen receptor-T cell therapy.

Neurological implications of chimeric antigen receptor-T cell therapy.

Journal: BMJ neurology open
Published: December 10, 2025

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.

Journal: Journal of neurology
Published: November 01, 2025

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal: Journal of neurology
Published: September 16, 2025

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

Journal: CNS drugs
Published: September 04, 2025

Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease.

Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease.

Journal: Frontiers in psychiatry
Published: July 14, 2025

Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry.

Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry.

Journal: Therapeutic advances in neurological disorders
Published: July 02, 2025

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.

Journal: JAMA neurology
Published: April 14, 2025

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data.

Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data.

Journal: NPJ digital medicine
Published: February 13, 2025

Depicting multiple sclerosis disease course using lesion parenchymal fraction: a quantified expression of the topographical model of multiple sclerosis.

Depicting multiple sclerosis disease course using lesion parenchymal fraction: a quantified expression of the topographical model of multiple sclerosis.

Journal: Brain communications
Published: January 13, 2025
Showing 1-12 of 22

Last Updated: 09/26/2026